These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1656 related articles for article (PubMed ID: 16670409)

  • 1. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?
    Doggrell SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2169-73. PubMed ID: 17020440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.
    Weiss RD; O'malley SS; Hosking JD; Locastro JS; Swift R;
    J Stud Alcohol Drugs; 2008 Nov; 69(6):878-84. PubMed ID: 18925346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between medication adherence and treatment outcomes: the COMBINE study.
    Zweben A; Pettinati HM; Weiss RD; Youngblood M; Cox CE; Mattson ME; Gorroochurn P; Ciraulo D
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1661-9. PubMed ID: 18616687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
    Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
    Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.
    COMBINE Study Research Group
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1123-31. PubMed ID: 12878918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.
    Hartzler B; Witkiewitz K; Villarroel N; Donovan D
    Psychol Addict Behav; 2011 Jun; 25(2):269-78. PubMed ID: 21443293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.
    Gueorguieva R; Wu R; Krystal JH; Donovan D; O'Malley SS
    Addict Behav; 2013 May; 38(5):2119-27. PubMed ID: 23435273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.
    Subbaraman MS; Metrik J; Patterson D; Swift R
    Addiction; 2017 Apr; 112(4):685-694. PubMed ID: 27865015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study.
    DeSantis SM; Bandyopadhyay D; Baker NL; Randall PK; Anton RF; Prisciandaro JJ
    Drug Alcohol Depend; 2013 Sep; 132(1-2):244-50. PubMed ID: 23566774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.
    Ray LA; Oslin DW
    Drug Alcohol Depend; 2009 Dec; 105(3):256-8. PubMed ID: 19717248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.